Delivery Order SPE2DR25D1002-SPE2DR26FGM5Y
- Not listed
- The Defense Logistics Agency awarded a $1,687.48 delivery order to AmerisourceBergen Drug Corp on August 8, 2025, for ProQuad vials with a completion date of August 29, 2025. This firm fixed-price, non-set-aside contract is being performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. As a child order under a larger contract vehicle, this delivery order leverages AmerisourceBergen's established relationships with DLA for pharmaceutical supply to...
- The Defense Logistics Agency awarded a delivery order valued at $5,480.80 to AmerisourceBergen Drug Corp for ProQuad vials, a combination vaccine product. The contract, issued on September 10, 2025, with an ultimate completion date of October 1, 2025, represents a firm fixed-price delivery order with no set-aside designation. Performance will take place at the contractor's corporate office location in Conshohocken, Pennsylvania. This award is a child order under AmerisourceBergen Drug Corp's...
- The Defense Logistics Agency awarded a delivery order valued at $26,281.90 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of November 14, 2025. This is a firm fixed-price delivery order with no set-aside designation, competitively awarded on October 23, 2025. The work will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. ProQuad is a combination vaccine providing immunization against measles, mumps, rubella, and...
- The Defense Logistics Agency awarded a delivery order valued at $13,271.75 to AmerisourceBergen Drug Corp for ProQuad vials, with a completion date of November 28, 2025. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed at the contractor's Corporate Office location in Conshohocken, Pennsylvania. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal medical supply vendor, was selected to deliver this...
- The Defense Logistics Agency awarded a $6,538.48 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of November 25, 2025. This contract represents a competitively awarded, firm fixed-price delivery order with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, serves as a critical pharmaceutical distributor for federal medical procurement needs and is performing the work at its corporate office...
- The Defense Logistics Agency awarded a $23,588.40 firm fixed-price delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of January 6, 2026. This is a non-set-aside competitive award issued as a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The delivery order will be performed at AmerisourceBergen's corporate office...
- The Defense Logistics Agency awarded a $5,012.07 delivery order to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of January 28, 2026. This competitively awarded, firm fixed-price contract represents a child delivery order under AmerisourceBergen's parent company Cencora, Inc.'s larger Indefinite Delivery Contract with DLA Troop Support Medical. The place of performance is Conshohocken, Pennsylvania, the location of AmerisourceBergen's corporate headquarters....
- AmerisourceBergen Drug Corp was awarded a delivery order valued at $8,437.20 by the Defense Logistics Agency on September 2, 2025, for the supply of ProQuad vials with a completion date of September 23, 2025. This is a firm fixed-price contract with no set-aside designation, competitively awarded to the pharmaceutical distributor's Corporate Office division. The place of performance is AmerisourceBergen's headquarters in Conshohocken, Pennsylvania. This delivery order operates under...
- The Defense Logistics Agency awarded a delivery order valued at $1,602.56 to AmerisourceBergen Drug Corp for ProQuad vials, with a completion date of November 21, 2025. This is a firm fixed price, competitively awarded contract with no set-aside designation. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, is a major pharmaceutical distributor serving as a critical vendor for federal medical procurement, particularly supporting military and veteran healthcare systems....
- The Defense Logistics Agency awarded a delivery order valued at $1,687.48 to AmerisourceBergen Drug Corp for ProQuad vials, with an ultimate completion date of September 11, 2025. This competitively awarded, firm fixed-price delivery order represents a small-value transaction within AmerisourceBergen's broader pharmaceutical supply relationship with the federal government. The contract specifies performance at the contractor's corporate office location in Conshohocken, Pennsylvania. This...
- SPE2DR25D1002Indefinite Delivery Contract
- SPE2DR25D1002-SPE2DR26FGM5YDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,637.80 to AmerisourceBergen Drug Corp for ProQuad vials, with a completion date of January 30, 2026. This is a firm fixed-price, competitively awarded contract with no set-aside designation. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate office. AmerisourceBergen Drug Corp operates as a subsidiary of Cencora, Inc. (doing business as AmerisourceBergen), a major pharmaceutical distributor providing critical medical products to federal government healthcare systems. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical, valued at up to $999,999,999.00 and extending through December 2026. The prime IDC serves as a comprehensive global pharmaceutical support vehicle enabling the company to supply an extensive range of pharmaceutical products and medical commodities—including vaccines, specialty medications, generic and brand-name drugs, and medical supplies—to support military healthcare programs and the Defense Health Agency worldwide. ProQuad is a combination vaccine used for immunization against measles, mumps, rubella, and varicella, representing the type of critical immunization product the DLA Medical Supply Chain procures for military personnel and beneficiaries.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.6k | 1/7/26 |